Share

Manufacturer

NgeneBio

Application

Gene mutations and response to targeted therapy

Products of interest

Batch Convert Unplayable Videos

Zymot ICSI

Next-Generation Sequencing System – NextSeq 2000

NgeneBio provides CE-IVD-certified library preparation kits and analysis software for clinical testing related to the diagnosis of cancer-related gene mutations.

Based on Illumina’s Next Generation Sequencing (NGS) technology platform to analyze all mutations related to target genes in cancer.

Compatible with Illumina’s Miseq/Miseq Dx system.

SOLIDaccuTest kit: Sequencing and detecting mutations of 84 genes through DNA analysis (CE-IVD) and 29 genes via RNA, in order to find the genetic causes leading to solid tissue cancers: Liver, lung , breast, rectum, prostate, etc.

Biomedic's solution

With the mission to bring to Vietnam market new generation NGS sequencing solutions and clinical reporting and analysis software for cancer target genes, achieving CE-IVD standard certification for standard tests used in laboratory tests. With the highest precision in medicine, Biomedic is proud to bring to customers the pioneering technology from NgeneBio.
The broad spectrum of products includes:
  • BRCAacuTest Plus: Sequencing, detecting mutations in 2 genes BRCA 1 and BRCA2 – mutations closely related to breast cancer and ovarian cancer on both inherited and acquired lines.
  • HEMEaccuTest kit: Sequencing, detecting mutations in 108 genes through DNA analysis (CE-IVD) and 53 genes through RNA, in order to find the genetic causes leading to blood cancers including: Leukemia acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndromes/myelopathies (MDS/MPN), multiple myeloma (MM), lymphoma.
  • SOLIDaccuTest kit: Sequencing and detecting mutations of 84 genes through DNA analysis (CE-IVD) and 29 genes via RNA, in order to find out the genetic causes leading to solid tissue cancers: Liver, lung , breast, rectum, prostate, etc.
  • NgeneAnalySys analysis software aims to analyze, produce clinical reports, explain mutations, roles and suggest targeted drugs and treatments in an easy to understand way for physicians.

Product

Solution: NgeneBio – SOLIDaccuTest™

SOLIDaccuTest™ is an excellent tool to explorer variants associated with solid tumors using a comprehensive method of next-generation sequencing (NGS). It reflects the latest research trends and is optimized for the medical purpose by selecting essential genes of solid tumors including lung, colon, breast, skin brain, gastric, ovarian cancers, etc.

 

Share

Manufacturer

NgeneBio

Application

Gene mutations and response to targeted therapy

Products of interest

Batch Convert Unplayable Videos

Zymot ICSI

Next-Generation Sequencing System – NextSeq 2000